Lombard Odier Asset Management Europe Ltd Makes New Investment in Option Care Health, Inc. (NASDAQ:OPCH)

Lombard Odier Asset Management Europe Ltd bought a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCHFree Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 340,576 shares of the company’s stock, valued at approximately $9,434,000. Lombard Odier Asset Management Europe Ltd owned 0.20% of Option Care Health as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Wellington Management Group LLP lifted its holdings in Option Care Health by 157.1% in the fourth quarter. Wellington Management Group LLP now owns 7,445,556 shares of the company’s stock worth $250,841,000 after buying an additional 4,549,164 shares during the period. Massachusetts Financial Services Co. MA purchased a new stake in Option Care Health in the second quarter worth $68,003,000. Norges Bank bought a new position in Option Care Health in the fourth quarter worth $64,343,000. Magnetar Financial LLC lifted its position in Option Care Health by 124.8% during the second quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock valued at $68,750,000 after buying an additional 1,377,929 shares during the period. Finally, Hood River Capital Management LLC boosted its holdings in shares of Option Care Health by 77.2% during the 2nd quarter. Hood River Capital Management LLC now owns 1,729,029 shares of the company’s stock valued at $47,894,000 after buying an additional 753,208 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. JMP Securities assumed coverage on shares of Option Care Health in a research report on Tuesday, July 16th. They set an “outperform” rating and a $36.00 price target for the company. Barrington Research boosted their price target on Option Care Health from $38.00 to $40.00 and gave the stock an “outperform” rating in a research report on Thursday, August 1st.

Read Our Latest Stock Report on OPCH

Insider Activity at Option Care Health

In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the sale, the director now directly owns 21,339 shares of the company’s stock, valued at $663,429.51. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now owns 247,317 shares of the company’s stock, valued at $7,654,461.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the company’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. The disclosure for this sale can be found here. 0.64% of the stock is owned by corporate insiders.

Option Care Health Stock Performance

Shares of NASDAQ OPCH opened at $31.90 on Monday. The firm’s 50-day moving average price is $31.20 and its 200-day moving average price is $30.44. Option Care Health, Inc. has a 52-week low of $26.11 and a 52-week high of $34.63. The company has a market cap of $5.54 billion, a PE ratio of 20.99, a PEG ratio of 2.46 and a beta of 1.29. The company has a quick ratio of 1.36, a current ratio of 1.76 and a debt-to-equity ratio of 0.78.

Option Care Health (NASDAQ:OPCHGet Free Report) last posted its earnings results on Wednesday, July 31st. The company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.03. The company had revenue of $1.23 billion for the quarter, compared to the consensus estimate of $1.17 billion. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. Option Care Health’s revenue was up 14.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.63 earnings per share. As a group, analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current year.

Option Care Health Company Profile

(Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Further Reading

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCHFree Report).

Institutional Ownership by Quarter for Option Care Health (NASDAQ:OPCH)

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.